Comparing primary tumors and metastatic nodes in head and neck cancer using intravoxel incoherent motion imaging: A preliminary experience

Journal of Computer Assisted Tomography

Volumn 37, Issue 3, 2013, Pages 346-352

  Lu, Yonggang ^a   Jansen, Jacobus F A ^b   Stambuk, Hilda E ^c   Gupta, Gaorav ^c   Lee, Nancy ^c   Gonen, Mithat ^c   Moreira, Andre ^c   Mazaheri, Yousef ^a,c   Patel, Snehal G ^a   Deasy, Joseph O ^a   Shah, Jatin P ^a   Shukla Dave, Amita ^a,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Department of Radiology ^*  (United States)

Author keywords

head and neck (HN) cancer; intravoxel incoherent motion imaging (IVIM); metastatic neck node; primary tumor

Indexed keywords

DISEASES; MAGNETIC RESONANCE IMAGING; PATIENT TREATMENT;

HEAD-AND-NECK CANCER; HEAD-AND-NECK TUMOR; INTRAVOXEL INCOHERENT MOTION IMAGING; INTRAVOXEL INCOHERENT MOTIONS; METASTATIC NECK NODE; MOTION IMAGING; OVERALL SURVIVAL; PRIMARY TUMOR; PROGRESSION FREE SURVIVAL; TUMOR METASTASIS;

TUMORS;

ADULT; ARTICLE; CLINICAL ARTICLE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; INTRAVOXEL INCOHERENT MOTION; MALE; MOTION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL;

EID: 84878853156     PISSN: 03638715     EISSN: 15323145     Source Type: Journal    
DOI: 10.1097/RCT.0b013e318282d935     Document Type: Article

References (43)

1. Forastiere AA, Trotti A, Pfister DG, et al. Head and neck cancer: recent advances and new standards of care. J Clin Oncol. 2006;24:2603-2605.
2. Awada A, de Castro G Jr. Head and neck cancer emerging strategies: advances and new challenges. Curr Opin Oncol. 2009;21:191-193.
3. Stambuk HE, Karimi S, Lee N, et al. Oral cavity and oropharynx tumors. Radiol Clin North Am. 2007;45:1-20.
4. Snow GB, van den Brekel MW, Leemans CR, et al. Surgical management of cervical lymph nodes in patients with oral and oropharyngeal cancer. Recent Results Cancer Res. 1994;134:43-55.
5. Baatenburg de Jong RJ, Hermans J, Molenaar J, et al. Prediction of survival in patients with head and neck cancer. Head Neck. 2001;23:718-724.
6. Mukherji SK, O'Brien SM, Gerstle RJ, et al. Tumor volume: an independent predictor of outcome for laryngeal cancer. J Comput Assist Tomogr. 1999;23:50-54.
7. Rudat V, Dietz A, Schramm O, et al. Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy. Radiother Oncol. 1999;53:119-125.
8. Shah GV, Wesolowski JR, Ansari SA, et al. New directions in head and neck imaging. J Surg Oncol. 2008;97:644-648.
9. de Bree R, Castelijns JA, Hoekstra OS, et al. Advances in imaging in the work-up of head and neck cancer patients. Oral Oncol. 2009;45:930-935.
10. Chawla S, Kim S, Wang S, et al. Diffusion-weighted imaging in head and neck cancers. Future Oncol. 2009;5:959-975.
11. Padhani AR. Diffusion magnetic resonance imaging in cancer patient management. Semin Radiat Oncol. 2011;21:119-140.
12. Sumi M, Sakihama N, Sumi T, et al. Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. AJNR Am J Neuroradiol. 2003;24: 1627-1634.
13. Koc O, Paksoy Y, Erayman I, et al. Role of diffusion weighted MR in the discrimination diagnosis of the cystic and/or necrotic head and neck lesions. Eur J Radiol. 2007;62:205-213.
14. Jansen JF, Stambuk HE, Koutcher JA, et al. Non-gaussian analysis of diffusion-weighted MR imaging in head and neck squamous cell carcinoma: a feasibility study. AJNR Am J Neuroradiol. 2010;31: 741-748.
15. Vandecaveye V, De Keyzer F, Nuyts S, et al. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. Int J Radiat Oncol Biol Phys. 2007;67:960-971.
16. Kato H, Kanematsu M, Tanaka O, et al. Head and neck squamous cell carcinoma: usefulness of diffusion-weighted MR imaging in the prediction of a neoadjuvant therapeutic effect. Eur Radiol. 2009;19:103-109.
17. Le Bihan D, Breton E, Lallemand D, et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988;168:497-505.
18. Le Bihan D. Intravoxel incoherent motion perfusion MR imaging: a wake-up call. Radiology. 2008;249:748-752.
19. Le Bihan D, Breton E, Lallemand D, et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology. 1986;161:401-407.
20. Luciani A, Vignaud A, Cavet M, et al. Liver cirrhosis: intravoxel incoherent motion MR imaging-pilot study. Radiology. 2008;249: 891-899.
21. Qi J, Olsen NJ, Price RR, et al. Diffusion-weighted imaging of inflammatory myopathies: polymyositis and dermatomyositis. J Magn Reson Imaging. 2008;27:212-217.
22. Riches SF, Hawtin K, Charles-Edwards EM, et al. Diffusion-weighted imaging of the prostate and rectal wall: comparison of biexponential and monoexponential modelled diffusion and associated perfusion coefficients. NMR Biomed. 2009;22:318-325.
23. Lemke A, Laun FB, Klau M, et al. Differentiation of pancreas carcinoma from healthy pancreatic tissue using multiple b-values: comparison of apparent diffusion coefficient and intravoxel incoherent motion derived parameters. Investigative Radiology. 2009;44:769-775.
24. Sigmund EE, Cho GY, Kim S, et al. Intravoxel incoherent motion imaging of tumor microenvironment in locally advanced breast cancer. Magn Reson Med. 2011;65:1437-1447.
25. Moore RJ, Issa B, Tokarczuk P, et al. In vivo intravoxel incoherent motion measurements in the human placenta using echo-planar imaging at 0.5 T. Magn Reson Med. 2000;43:295-302.
26. Gudbjartsson H, Patz S. The Rician distribution of noisy MRI data. Magn Reson Med. 1995;34:910-914.
27. Kristoffersen A. Statistical assessment of non-Gaussian diffusion models. Magn Reson Med. 2011;66:1639-1648.
28. Constantinides CD, Atalar E,McVeigh ER. Signal-to-noise measurements in magnitude images from NMR phased arrays. Magn Reson Med. 1997;38:852-857.
29. Kristoffersen A. Optimal estimation of the diffusion coefficient from non-averaged and averaged noisy magnitude data. J Magn Reson. 2007;187:293-305.
30. More JJ, Sorensen DC. Computing a trust region step. Siam Journal on Scientific and Statistical Computing. 1983;4:553-572.
31. Lee CH, Choi JW, Kim KA, et al. Usefulness of standard deviation on the histogram of ultrasound as a quantitative value for hepatic parenchymal echo texture; preliminary study. Ultrasound Med Biol. 2006;32:1817-1826.
32. Posner MR, Hershock DM, Blajman CR, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007;357:1705-1715.
33. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937-1944.
34. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945-1952.
35. PadhaniAR, KohDM. DiffusionMR imaging for monitoring of treatment response. Magn Reson Imaging Clin N Am. 2011;19:181-209.
36. Humphries PD, Sebire NJ, Siegel MJ, et al. Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity. Radiology. 2007;245:848-854.
37. Zelhof B, Pickles M, Liney G, et al. Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer. BJU Int. 2009;103:883-888.
38. Figueiras RG, Padhani AR, Goh VJ, et al. Novel oncologic drugs: what they do and how they affect images. Radiographics. 2011;31:2059-2091.
39. Jansen JF, Koutcher JA, Shukla-Dave A. Non-invasive imaging of angiogenesis in head and neck squamous cell carcinoma. Angiogenesis. 2010;13:149-160.
40. Suh JY, Cho G, Song Y, et al. Is apparent diffusion coefficient reliable and accurate for monitoring effects of antiangiogenic treatment in a longitudinal study? J Magn Reson Imaging. 2012;35:1430-1436.
41. Koh DM, Blackledge M, Collins DJ, et al. Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial. Eur Radiol. 2009;19:2728-2738.
42. Berrak S, Chawla S, Kim S, et al. Diffusion weighted imaging in predicting progression free survival in patients with squamous cell carcinomas of the head and neck treated with induction chemotherapy. Acad Radiol. 2011;18:1225-1232.
43. Kim S, Loevner L, Quon H, et al. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res. 2009;15:986-994.